R. LaDuane  Clifton net worth and biography

R. Clifton Biography and Net Worth

As Chief Financial Officer, Secretary and Treasurer, Mr. Clifton is responsible for the company’s financial, operating and compliance activities. Mr. Clifton brings to KemPharm significant public company experience, along with expertise in managed care contracting and strategic leadership covering operations, compliance, investor relations and business development.

Prior to joining KemPharm, Mr. Clifton served as the Chief Financial Officer, Secretary and Treasurer of The LGL Group, Inc., a publicly-held global producer of highly-engineered electronic components and services. Mr. Clifton also previously served as the Chief Financial Officer of a21, Inc., a publicly-held holding company with businesses in stock photography and the online retail and manufacture of framed art, as well as a variety of finance, medical cost analysis, and managed care provider contracting roles with Aetna, Inc.

Mr. Clifton was an auditor with KPMG, LLP, and received his B.B.A. and M.B.A. from the University of North Florida. Mr. Clifton is a certified public accountant licensed by the State of Florida.

How do I contact R. LaDuane Clifton?

The corporate mailing address for Mr. Clifton and other Zevra Therapeutics executives is 1180 Celebration Boulevard Suite 103, Celebration FL, 34747. Zevra Therapeutics can also be reached via phone at (321) 939-3416 and via email at [email protected]. Learn More on R. LaDuane Clifton's contact information.

Has R. LaDuane Clifton been buying or selling shares of Zevra Therapeutics?

R. LaDuane Clifton has not been actively trading shares of Zevra Therapeutics during the last ninety days. Learn More on R. LaDuane Clifton's trading history.

Who are Zevra Therapeutics' active insiders?

Zevra Therapeutics' insider roster includes R. Clifton (CFO), Travis Mickle (CEO), Richard Pascoe (Chairman), and David Tierney (Director). Learn More on Zevra Therapeutics' active insiders.

R. LaDuane Clifton Insider Trading History at Zevra Therapeutics

See Full Table

R. LaDuane Clifton Buying and Selling Activity at Zevra Therapeutics

This chart shows R. Laduane Clifton's buying and selling at Zevra Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Zevra Therapeutics Company Overview

Zevra Therapeutics logo
KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses on the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $5.51
Low: $4.48
High: $6.27

2 Week Range

Now: N/A

Volume

64,100 shs

Average Volume

189,500 shs

Market Capitalization

$200.47 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.16